Skip to main content

Table 3 Hazard risk of TP53 mutations on familial and sporadic ovarian cancer cases.

From: TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival

  # cases HR CI (95%) p-value
Familial Cases 30    
TP53 no mutation 14 1 (ref)   
TP53 mutation 16 1.64 0.71 – 3.78 0.25
Sporadic cases 100    
TP53 no mutation 26 1 (ref)   
TP53 mutation 76 0.96 0.55 – 1.66 0.88